Status:
ENROLLING_BY_INVITATION
Integration of VR and AR Dementia Prevention Health Education Progrom for Older Adults With Mild Cognitive Impairment
Lead Sponsor:
National Taiwan Normal University
Conditions:
Mild Cognitive Impairment (MCI)
Dementia
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The goal of this randomized controlled trial is to evaluate the effectiveness of Virtual Reality (VR)-based cognitive health education for older adults with mild cognitive impairment (MCI) in Taiwan. ...
Detailed Description
This study is a randomized controlled trial (RCT) aimed at evaluating the effectiveness of a Virtual Reality (VR)-based cognitive health education program for older adults in Taiwan who show signs of ...
Eligibility Criteria
Inclusion
- Adults aged 65 years and older.
- AD-8 score of 2 or higher, indicating possible cognitive impairment.
- Ability to understand and follow basic instructions in Mandarin or Taiwanese.
- Capacity to provide informed consent or have a legally authorized representative to provide consent.
- Ability to tolerate and interact with VR equipment (e.g., wearing a VR headset, using hand controllers).
Exclusion
- Diagnosed with moderate to severe dementia (i.e., unable to follow basic instructions).
- Presence of severe visual, auditory, or motor impairments that hinder interaction with VR devices.
- Diagnosed with severe psychiatric disorders (e.g., schizophrenia, major depressive disorder).
- Unable to communicate effectively in Mandarin or Taiwanese.
Key Trial Info
Start Date :
September 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06888986
Start Date
September 30 2024
End Date
December 1 2025
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan Normal University
Taipei, Taiwan